Position in BIOA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$2,370,944
+$577,486 QoQ
Shares Held
135,560
0.0% QoQ
Ownership
0.295%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $25,810,127 across 10 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
277,848 | $9,413,490 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
494,378 | $8,879,028 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
26,913 | $1,721,086 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
133,000 | $1,330,000 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,842 | $1,294,931 | |
| 6 | INM |
InMed Pharmaceuticals Inc.
|
800,000 | $1,240,000 | |
| 7 | TXMD |
TherapeuticsMD, Inc.
|
342,447 | $756,807 | |
| 8 | EOLS |
Evolus, Inc.
|
100,000 | $694,000 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,370,944 | 135,560 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,793,458 | 135,560 | Shares | Sole | 2026-02-18 | |
| 2025-12-31 | $1,793,458 | 135,560 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $11,054,829 | 1,880,073 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $8,000,317 | 1,937,123 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,651,336 | 971,100 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $712,384 | 123,037 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||